BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29531004)

  • 21. Different phenotypes in recessive dystrophic epidermolysis bullosa patients sharing the same mutation in compound heterozygosity with two novel mutations in the type VII collagen gene.
    Gardella R; Zoppi N; Zambruno G; Barlati S; Colombi M
    Br J Dermatol; 2002 Sep; 147(3):450-7. PubMed ID: 12207583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotype-phenotype correlation in italian patients with dystrophic epidermolysis bullosa.
    Gardella R; Castiglia D; Posteraro P; Bernardini S; Zoppi N; Paradisi M; Tadini G; Barlati S; McGrath JA; Zambruno G; Colombi M
    J Invest Dermatol; 2002 Dec; 119(6):1456-62. PubMed ID: 12485454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes.
    Varki R; Sadowski S; Uitto J; Pfendner E
    J Med Genet; 2007 Mar; 44(3):181-92. PubMed ID: 16971478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One Novel Frameshift Mutation on Exon 64 of COL7A1 Gene in an Iranian Individual Suffering Recessive Dystrophic Epidermolysis Bullosa.
    Khaniani MS; Sohrabi N; Derakhshan NM; Derakhshan SM
    Ann Clin Lab Sci; 2015; 45(5):582-4. PubMed ID: 26586712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel COL7A1 mutation in a Korean patient with Hallopeau-Siemens recessive dystrophic epidermolysis bullosa.
    Park J; Chae H; Kim M; Kim Y; Park IY; Shin JC; Park YM
    Genet Mol Res; 2013 Mar; 12(1):678-82. PubMed ID: 23546949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aplasia cutis congenita with dystrophic epidermolysis bullosa: clinical and mutational study.
    Chiaverini C; Charlesworth A; Fernandez A; Barbarot S; Bessis D; Bodemer C; Bursztejn AC; Cobo AM; Del Rio M; D'Incan M; Labrèze C; Langlet C; Mazereeuw J; Miquel J; Vabres P; Meneguzzi G; Lacour JP
    Br J Dermatol; 2014 Apr; 170(4):901-6. PubMed ID: 24252097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel biallelic variants in COL7A1 cause recessive dystrophic epidermolysis bullosa.
    Yang N; Ma Y; Yao H; Chang Q; Zhang V; Liang Z; Cai X
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1347. PubMed ID: 32537942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Splice site mutation in COL7A1 resulting in aberrant in-frame transcripts identified in a case of recessive dystrophic epidermolysis bullosa, pretibial.
    Masunaga T; Kubo A; Ishiko A
    J Dermatol; 2018 Jun; 45(6):742-745. PubMed ID: 29500833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological correlations of compound heterozygous COL7A1 mutations in recessive dystrophic epidermolysis bullosa.
    Dunnill MG; McGrath JA; Richards AJ; Christiano AM; Uitto J; Pope FM; Eady RA
    J Invest Dermatol; 1996 Aug; 107(2):171-7. PubMed ID: 8757758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico.
    Saeidian AH; Youssefian L; Moreno Trevino MG; Fortuna G; Vahidnezhad H; Atanasova VS; Uitto J; Salas-Alanis JC; South AP
    Clin Exp Dermatol; 2018 Jul; 43(5):579-584. PubMed ID: 29473190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inversa type of recessive dystrophic epidermolysis bullosa is caused by specific arginine and glycine substitutions in type VII collagen.
    van den Akker PC; Mellerio JE; Martinez AE; Liu L; Meijer R; Dopping-Hepenstal PJ; van Essen AJ; Scheffer H; Hofstra RM; McGrath JA; Jonkman MF
    J Med Genet; 2011 Mar; 48(3):160-7. PubMed ID: 21113014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and allelic heterogeneity in dystrophic epidermolysis bullosa- lessons from an Indian cohort.
    Gupta D; Jayashankar C; Srinivas M; Baraka Vishwanathan G; Reddy KR; Kubba A; Batrani M; Hiremagalore R
    PLoS One; 2023; 18(8):e0289558. PubMed ID: 37556444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The G2028R glycine substitution mutation in COL7A1 leads to marked inter-familiar clinical heterogeneity in dominant dystrophic epidermolysis bullosa.
    Nakamura H; Sawamura D; Goto M; Sato-Matsumura KC; LaDuca J; Lee JY; Masunaga T; Shimizu H
    J Dermatol Sci; 2004 May; 34(3):195-200. PubMed ID: 15113589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identical glycine substitution mutations in type VII collagen may underlie both dominant and recessive forms of dystrophic epidermolysis bullosa.
    Almaani N; Liu L; Dopping-Hepenstal PJ; Lai-Cheong JE; Wong A; Nanda A; Moss C; Martinéz AE; Mellerio JE; McGrath JA
    Acta Derm Venereol; 2011 May; 91(3):262-6. PubMed ID: 21448560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of 18 new mutations in COL7A1 in recessive dystrophic epidermolysis bullosa provides evidence for distinct molecular mechanisms underlying defective anchoring fibril formation.
    Hovnanian A; Rochat A; Bodemer C; Petit E; Rivers CA; Prost C; Fraitag S; Christiano AM; Uitto J; Lathrop M; Barrandon Y; de Prost Y
    Am J Hum Genet; 1997 Sep; 61(3):599-610. PubMed ID: 9326325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case report. Novel and recurrent COL7A1 mutations in Chinese patients with dystrophic epidermolysis bullosa pruriginosa.
    Zhu KJ; Zhu CY; Zhou Y; Fan YM
    Genet Mol Res; 2014 Sep; 13(3):7587-92. PubMed ID: 25222259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The international dystrophic epidermolysis bullosa patient registry: an online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations.
    van den Akker PC; Jonkman MF; Rengaw T; Bruckner-Tuderman L; Has C; Bauer JW; Klausegger A; Zambruno G; Castiglia D; Mellerio JE; McGrath JA; van Essen AJ; Hofstra RM; Swertz MA
    Hum Mutat; 2011 Oct; 32(10):1100-7. PubMed ID: 21681854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three homozygous PTC mutations in the collagen type VII gene of patients affected by recessive dystrophic epidermolysis bullosa: analysis of transcript levels in dermal fibroblasts.
    Gardella R; Zoppi N; Ferraboli S; Marini D; Tadini G; Barlati S; Colombi M
    Hum Mutat; 1999; 13(6):439-52. PubMed ID: 10408773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic base editing and prime editing of COL7A1 mutations in recessive dystrophic epidermolysis bullosa.
    Hong SA; Kim SE; Lee AY; Hwang GH; Kim JH; Iwata H; Kim SC; Bae S; Lee SE
    Mol Ther; 2022 Aug; 30(8):2664-2679. PubMed ID: 35690907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Forty-two novel COL7A1 mutations and the role of a frequent single nucleotide polymorphism in the MMP1 promoter in modulation of disease severity in a large European dystrophic epidermolysis bullosa cohort.
    Kern JS; Grüninger G; Imsak R; Müller ML; Schumann H; Kiritsi D; Emmert S; Borozdin W; Kohlhase J; Bruckner-Tuderman L; Has C
    Br J Dermatol; 2009 Nov; 161(5):1089-97. PubMed ID: 19681861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.